Previous close | 9.80 |
Open | 9.80 |
Bid | 7.20 |
Ask | 8.80 |
Strike | 30.00 |
Expiry date | 2024-07-19 |
Day's range | 9.80 - 9.80 |
Contract range | N/A |
Volume | |
Open interest | 3 |
Despite a flat performance over the last week, the United States stock market has seen an impressive 24% increase over the past year with earnings expected to grow by 15% annually. In such a thriving environment, undervalued small-cap stocks like AtriCure, which show promising insider actions, could present intriguing opportunities for investors looking for potential growth.
As the United States grapples with mixed economic signals, evidenced by recent downturns in key indices like the S&P 500 and heightened concerns over housing and job markets, investors are navigating a complex landscape. In such an environment, exploring undervalued small-cap stocks with significant insider actions might offer unique opportunities for those looking to potentially capitalize on market inefficiencies.
TimesSquare Capital Management, an equity investment management company, released its “U.S. Small Cap Growth Strategy” first-quarter 2024 investor letter. A copy of the letter can be downloaded here. In the quarter the fund returned 5.77% (net), compared to a 7.58% return for the Russell 2000 Growth Index. Despite a decline in many equity markets in […]